PotNetwork Holding, Inc. (OTCMKTS:POTN) has positioned itself as one of the leaders in the growing hemp-derived cannabidiol (CBD) industry. Its aggressive marketing and expansion strategies are expected to help the company continue to propel in the CBD market in the United States and across the world.
Hemp-derived CBD is the fastest growing segment of the multibillion-dollar legal cannabis and hemp industry. PotNetwork’s wide range of hemp-based product portfolio allows the company to benefit from the hemp market, which is projected to grow at a compounded annual rate of approximately 53 percent in the next three years.
PotNetwork Holding serves as the holding company of its subsidiaries, First Capital Venture Co., the owner of Diamond CBD. Diamond CBD is dedicated to research, development and multinational distribution of premium hemp extracts, specifically CBD oil and specialty products.
Diamond CBD, PotNetwork’s wholly owned subsidiary, has shown a strong growth this 2017. Its third-quarter revenues jumped by 29 percent to over $4.4 million from the previous quarter. The company reported that its October revenues reached over $1.6 million, and its revenues in November also exceeded $1.6 million, driven by the growing popularity of its premium quality products among celebrities and media sources in the country.
A strong performer in CBD market
By 2020, the hemp industry is expected to reach $1.8 billion, $450 million of which will be from hemp-derived CBD products. A SeeThru Equity research sees PotNetwork as a speculative play in this market in the U.S. Its Diamond CBD arm aims to increase its revenue to an estimated $8 million for the 2017 financial year from $1.6 million for the entire 2016. With its month over month advancement this year, the company is on track to hit its target.
Diamond CBD’s aforementioned revenues also went beyond expectations; its great market performance situates PotNetwork Holding for a record-breaking year-end.
Aside from its record numbers, Diamond CBD has been showcasing its products across high profile trade shows and conventions. These efforts in publicity are expected to further grow the company’s brand recognition and increase order flow and the predilection for its products. Over 10,000 retail stores are now selling PotNetwork’s products, according to the company.
The Surf Expo in Florida appears to have paved the way to new business opportunities while the company generated over $230,000 of purchase orders in just three days at the Las Vegas CHAMPS Show. Its exhibit at the ASD Market Week gave its products exposure to over 45,000 buyers from more than 88 countries.
PotNetwork Holding’s efforts are being recognized as well, with the Huffington Post lauding the company as “one of the five notable CBD revolution industry leaders.”
Expanding the reach of its products
Aside from taking a leading spot in the hemp market in the U.S., PotNetwork is planning to introduce its products in China, Peru, Bolivia, Chile, and Ecuador. CBD oil’s ability to help prevent Alzheimer’s disease, as well as reduce anxiety, stress and other ailments, would make PotNetwork’s products attractive to Chinese consumers who are known to embrace homeopathic and natural remedies for illnesses.
PotNetwork has over 15 popular brands, including Chill Gummies, Relax Gummies, Liquid Gold vape liquid, flavored CBD Hemp Oils, Blue CBD Crystals Isolate, Relax Extreme CBD collection, and more.
Unlike marijuana CBD, hemp CBD extracts are legal in all 50 states in America, although most states are yet to join South Carolina and Arizona in legalizing the cultivation of industrial hemp. Hemp-derived CBD is not psychoactive, which means the user would not get high. Moreover, it was found to have a wide range of therapeutic benefits and neuroprotective properties.
PotNetwork currently extracts CBD from imported hemp plants. A regulatory tailwind in the U.S. will benefit the company’s market expansion, along with its organic growth strategy through aggressive marketing campaigns.
With these, the company aims to increase its share price to $0.25 from the recent $0.06, which seems realistic given the material development in its performance over the past quarters. There are still remaining industry challenges to overcome, but PotNetwork has been recognized as one of the few companies leading the CBD revolution globally.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
Cryptocurrency news of the week you can’t miss
One of the most important events in the history of Bitcoin will be May halving in 2020. The award of...
Africa attracts investors
The fact is: Africa, which for a long time concluded agreements primarily with China, is attracting more and more foreign...
German startup invested $7 million in medical cannabis
Berlin startup Demecan has completed a Series A financing round of €7 million, invested by btov Partners and a single...
The global cannabis market will be worth $75 billion by 2025
The global legal cannabis market forecast reaches $75.6 billion by 2025, with an average annual growth rate of 28.3% over...
Biotechnology is on the trail of cancer
More and more people are getting cancer. In Germany alone, doctors diagnose around half a million new cancer patients every...